-+ 0.00%
-+ 0.00%
-+ 0.00%

VolitionRx joins French government-backed EUR 6.3 million DETECSEPS sepsis detection consortium

PUBT·09/17/2026 12:18:31
Listen to the news
VolitionRx joins French government-backed EUR 6.3 million DETECSEPS sepsis detection consortium
  • Volition joined the DETECSEPS consortium, backed by EUR 6.3 million in French government funding, to evaluate early sepsis detection.
  • AP-HP leads the project with Hospices Civils de Lyon, IDS France, Volition providing the Nu.Q NETs biomarker for real-world assessment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VolitionRX Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609170817PR_NEWS_EUPR__FR_FR50557) on September 17, 2026, and is solely responsible for the information contained therein.